Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.

Kamalov G, Deshmukh PA, Baburyan NY, Gandhi MS, Johnson PL, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2009 May;53(5):414-23. doi: 10.1097/FJC.0b013e3181a15e77.

2.

Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism.

Kamalov G, Ahokas RA, Zhao W, Shahbaz AU, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H385-94. doi: 10.1152/ajpheart.00593.2009. Epub 2009 Nov 13.

3.

Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism.

Kamalov G, Ahokas RA, Zhao W, Zhao T, Shahbaz AU, Johnson PL, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2010 Mar;55(3):248-54. doi: 10.1097/FJC.0b013e3181cf0090.

4.

Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone.

Thomas M, Vidal A, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2361-6. Epub 2007 Jul 6.

5.

Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.

Gandhi MS, Deshmukh PA, Kamalov G, Zhao T, Zhao W, Whaley JT, Tichy JR, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2008 Sep;52(3):245-52. doi: 10.1097/FJC.0b013e3181833eb8.

6.

Nebivolol: a multifaceted antioxidant and cardioprotectant in hypertensive heart disease.

Khan MU, Zhao W, Zhao T, Al Darazi F, Ahokas RA, Sun Y, Bhattacharya SK, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2013 Nov;62(5):445-51. doi: 10.1097/FJC.0b013e3182a0b5ff.

PMID:
23921314
7.

Mitochondria-targeted cardioprotection in aldosteronism.

Shahbaz AU, Kamalov G, Zhao W, Zhao T, Johnson PL, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2011 Jan;57(1):37-43. doi: 10.1097/FJC.0b013e3181fe1250.

8.

From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.

Zia AA, Kamalov G, Newman KP, McGee JE, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT.

Hypertens Res. 2010 Nov;33(11):1091-101. doi: 10.1038/hr.2010.159. Epub 2010 Sep 9. Review.

PMID:
20827279
9.

Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol.

Cheema Y, Sherrod JN, Zhao W, Zhao T, Ahokas RA, Sun Y, Gerling IC, Bhattacharya SK, Weber KT.

J Cardiovasc Pharmacol. 2011 Jul;58(1):80-6. doi: 10.1097/FJC.0b013e31821cd83c.

10.

Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.

Shahbaz AU, Zhao T, Zhao W, Johnson PL, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H636-44. doi: 10.1152/ajpheart.00900.2010. Epub 2010 Nov 12.

11.

Gene expression profiles of peripheral blood mononuclear cells reveal transcriptional signatures as novel biomarkers of cardiac remodeling in rats with aldosteronism and hypertensive heart disease.

Gerling IC, Ahokas RA, Kamalov G, Zhao W, Bhattacharya SK, Sun Y, Weber KT.

JACC Heart Fail. 2013 Dec;1(6):469-76. doi: 10.1016/S2213-1779(13)00374-0. Epub 2013 Dec 2.

12.

Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface.

Ahokas RA, Warrington KJ, Gerling IC, Sun Y, Wodi LA, Herring PA, Lu L, Bhattacharya SK, Postlethwaite AE, Weber KT.

Circ Res. 2003 Nov 14;93(10):e124-35. Epub 2003 Oct 23.

13.

ß-blocker timolol prevents arrhythmogenic Ca²⁺ release and normalizes Ca²⁺ and Zn²⁺ dyshomeostasis in hyperglycemic rat heart.

Tuncay E, Okatan EN, Vassort G, Turan B.

PLoS One. 2013 Jul 29;8(7):e71014. doi: 10.1371/journal.pone.0071014. Print 2013.

14.

The role of spironolactone on myocardial oxidative stress in rat model of streptozotocin-induced diabetes.

Mayyas F, Alzoubi KH, Bonyan R.

Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12242.

PMID:
27992114
15.

Tissue 65Zinc translocation in a rat model of chronic aldosteronism.

Selektor Y, Parker RB, Sun Y, Zhao W, Bhattacharya SK, Weber KT.

J Cardiovasc Pharmacol. 2008 Apr;51(4):359-64. doi: 10.1097/FJC.0b013e318165b96e.

16.

Reverse remodeling and recovery from cachexia in rats with aldosteronism.

Cheema Y, Zhao W, Zhao T, Khan MU, Green KD, Ahokas RA, Gerling IC, Bhattacharya SK, Weber KT.

Am J Physiol Heart Circ Physiol. 2012 Aug 15;303(4):H486-95. doi: 10.1152/ajpheart.00192.2012. Epub 2012 Jun 22.

17.

Zinc and the prooxidant heart failure phenotype.

Efeovbokhan N, Bhattacharya SK, Ahokas RA, Sun Y, Guntaka RV, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2014 Oct;64(4):393-400. doi: 10.1097/FJC.0000000000000125. Review.

18.

Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT.

Am J Pathol. 2002 Nov;161(5):1773-81.

19.

Hyperparathyroidism and the calcium paradox of aldosteronism.

Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT.

Circulation. 2005 Feb 22;111(7):871-8. Epub 2005 Feb 14.

PMID:
15710759
20.

Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements.

Goodwin KD, Sun Y, Weber KT, Bhattacharya SK, Ahokas RA, Gerling IC.

Am J Med Sci. 2006 Aug;332(2):73-78. doi: 10.1097/00000441-200608000-00004.

PMID:
16909053

Supplemental Content

Support Center